Navigation Links
Blood-thinning treatment standards changing for heart patients, new research shows
Date:12/9/2010

es into account the patient's age as well as other medical conditions, including congestive heart failure, hypertension, diabetes and prior stroke and is used by many guidelines to help make treatment recommendations for anticoagulant or blood-thinning therapy," Eckman says, adding that researchers also used outcomes from the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study to define a more contemporary risk of stroke among patients with atrial fibrillation.

The ATRIA study has followed outcomes in a large group of more than 13,500 patients with atrial fibrillation and has found that the risk of stroke has declined over the past two decades.

Researchers explored outcomes of four strategies: anticoagulate with warfarin; anticoagulate with a new, "safer" agent, using dabigatran (another anticoagulant) as the prototype; treat with aspirin; and no antithrombotic therapy.

"We used a standard computer program to build the model, analyze results and perform sensitivity analyses," Eckman says. "Our base case involved a hypothetical 69-year-old man with non-valvular atrial fibrillation who had no contraindications to warfarin therapy."

Researchers found that warfarin is preferred above a stroke rate of 1.7 percent per year, corresponding to a CHADS2 score of 0 using the historically higher rates of stroke of the older CHADS2 derivation cohort.

Eckman continues, "Using more contemporary and lower estimates of stroke risk raises the threshold for use of warfarin to a CHADS2 score of greater than or equal to 2 (moderate to high risk). However, anticoagulation with a new, 'safer' agent leads to a lowering of the threshold for anticoagulation to a stroke rate of 0.9 percent per year.

"Our analysis suggests that the 'tipping point,' the threshold of ischemic stroke risk below which anticoagulant therapy should be withheld and above which anticoagulant therapy should be prescribed, has changed," he says. "
'/>"/>

Contact: Katie Pence
katie.pence@uc.edu
513-558-4561
University of Cincinnati Academic Health Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Adding ipilimumab to standard chemotherapy treatment for late-stage lung cancer may improve survival
2. Weightlifting slashes lymphedema risk after breast cancer treatment
3. Autism breakthrough: Researchers identify possible treatment for impaired sociability
4. Even with helicopter EMS, hospital transfer can delay treatment for heart attacks
5. Stem cell advance a step forward for treatment of brain diseases
6. Scripps Research scientists awarded $2.35 million to study new obesity treatment
7. New therapies and gene target advance the treatment and understanding of hard-to-treat leukemias
8. New standards of care and novel treatment options for several forms of lymphoma unveiled
9. Studies highlight role of stem cell transplant procedures for blood cancer treatment
10. Medicare Cuts May Have Spurred Drop in Prostate Cancer Treatment
11. Spanish Oncology to establish a new standard treatment on breast cancer at early stages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Lecrae is ... been noted everywhere from Rolling Stone and The New York Times to Billboard Magazine ... life experiences are one of the many reasons why so many people are taking ...
(Date:6/30/2015)... New York, NY (PRWEB) , ... June 30, ... ... and students are critical in order to enhance successful student outcomes. According ... on the teacher’s capacity to adapt.” Teachers must be able to show “all ...
(Date:6/30/2015)... ... June 30, 2015 , ... Americans report feeling more stressed than ever ... mornings, which puts stressed out people right over the edge. , Almost half ... sleep deprivation every night. Sleeping pills now lead the list of the most prescribed ...
(Date:6/30/2015)... ... June 30, 2015 , ... Curly Hair Solutions™ is honoured to attend Cosmoprof ... the US, featuring products from all over the world. For the first time ever, ... line of hair styling products focused entirely on meeting the needs of all ...
(Date:6/29/2015)... (PRWEB) , ... June 30, 2015 , ... Sublime Beauty ... 50% Off offer. The oil, ideal for natural skincare and even culinary uses, ... easy way is something most people desire, and Oil Pulling can accomplish this. Oil ...
Breaking Medicine News(10 mins):Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 2Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 3Health News:Lessons On Leadership - Top 12 Global Teacher Bloggers Reveal the Best Strategies for Building Positive Leadership in Global Classrooms 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 3Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2
... Oct. 28 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Co., Inc., (Amex: ... traditional Chinese medicine ("TCM") based in Chengdu, China,today ... approved a $3,million stock repurchase program., On ... the Company to,repurchase up to $3.0 million of ...
... BPUR ) announced today that it has ... until March 16, 2009, to regain compliance,with Marketplace ... $1.00,for continued listing. The deadline would have been ... minimum bid price requirement because,of turmoil in the ...
... Dissatisfaction with Pain,Management, SAN FRANCISCO, Oct. 28 ... from large-scale rheumatoid arthritis (RA) surveys,collectively called the ... substantially less knowledge of RA therapies than their,physicians ... between,physicians and nurses over who should be charged ...
... Comply by November 1st, BRENTWOOD, Tenn., Oct. 28 ... will delay penalties until May 1, 2009 for,organizations not ... welcomed relief for those defined as "Creditors" who have ... deadline., Organizations affected by the FTC,s delay in ...
... this year,s liver meeting in San ... Oct. 28 The goal of researchers from the,Mayo Clinic ... determine the,effects of fatty liver disease in children up to ... nonalcoholic fatty liver disease,(NAFLD) is the most prevalent liver disease ...
... & Sullivan is,pleased to announce that the firm will ... Innovation Awards. The Awards will be announced,during a banquet ... San Antonio,Texas., The Healthcare Innovation Awards are given ... delivery and management of healthcare.,Such companies have shown success ...
Cached Medicine News:Health News:Tianyin Pharmaceutical Co., Inc. Authorizes $3.0 Million Stock Repurchase Program 2Health News:Tianyin Pharmaceutical Co., Inc. Authorizes $3.0 Million Stock Repurchase Program 3Health News:Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance 2Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 2Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 3Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 4Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 5Health News:FTC Extends Final Red Flag Compliance Deadline for Creditors 2Health News:Severe Health Risks Follow Adults Who Were Diagnosed With Nonalcoholic Fatty Liver Disease as Children 2Health News:Frost & Sullivan to Present the 2008 Excellence in Healthcare Innovation Awards 2Health News:Frost & Sullivan to Present the 2008 Excellence in Healthcare Innovation Awards 3
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ – Small Cap IR ... agreement to supply custom Arrayit blood card technology to ... vault on earth. Vivos offers an impervious, impenetrable and ... man, woman and child on Earth, a safe and ... Arrayit blood cards allow the rapid collection, separation, drying ...
(Date:6/30/2015)... 30, 2015  Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and ... results from a Category 3 human abuse ... extended-release, oral oxycodone product candidate in late-stage ... severe enough to require daily, around-the-clock opioid ...
(Date:6/30/2015)... England , June 30, 2015 ... acted as advisor to Chip-Man Technologies Oy (CMT) on ... (Yokogawa). The assets relate to CMTs world leading capabilities ... is the latest in a series of successful global ... PharmaVentures clients. Fintan Walton , CEO, ...
Breaking Medicine Technology:Small Cap IR - Empowering the Age of Genetic Enlightenment 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5PharmaVentures Completes M&A Deal for Technology in the Stem Cell & Regenerative Medicine Sector 2
... 6 TargeGen, Inc. today announced that,the Company,s ... and the,Company plans to initiate a multi-center clinical ... highly selective JAK2 inhibitor in,January, 2008. Additionally, TargeGen ... will be made at the 2007 ASH Conference,(Atlanta, ...
... Inc. (Nasdaq: BCRX ) today provided an ... Forodesine HCl Data to be Presented at American ... Chair, Dermatology, The University of,Texas M.D. Anderson Cancer ... Phase I/II clinical study of oral forodesine HCl ...
Cached Medicine Technology:TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH 2BioCryst Provides Forodesine HCl Update 2BioCryst Provides Forodesine HCl Update 3BioCryst Provides Forodesine HCl Update 4BioCryst Provides Forodesine HCl Update 5